Foresight News reports that the publicly traded company Tharimmune, Inc. has signed a private sale financing agreement with several institutions and accredited investors, planning to issue common stock at a price of $3.075 per share (or in the alternative of pre-financing warrants), with a total financing amount expected to be approximately $540 million, not including underwriting fees and other issuance costs. The financing is expected to be completed around November 6, 2025, subject to meeting customary closing conditions. The company plans to use the net proceeds from the financing to acquire Canton Coin (CC), which is used to support the interoperability and Settlement of the Canton network. Additionally, Tharimmune plans to operate additional validators on the Canton network as a Super Validator to earn more CC tokens. DRW and Liberty City Ventures are the main investors, with participants including ARK Invest, Bitwave, Broadridge, Clear Street, Copper, Digital Asset, Feynman Point Asset Management, Five North, Kaiko, Kenetic, Kraken, LendOS, Lukka, Nima Capital, MPCH, Obsidian Software, Polychain Capital, Proof Group, SBI Group, The Tie, Tradeweb Markets, and 7RIDGE. The Canton Foundation, as the regulatory body for the Canton network, is also participating in this transaction.